Clinical Trial Detail

Contact

Missing content? – Request curation!

Request curation for specific Genes, Variants, or PubMed publications.

Have questions, comments, or suggestions? - Let us know!

Email us at : ckbsupport@genomenon.com

NCT ID NCT06568939
Title A Study to Assess Adverse Events and How Intravenously (IV) Infused Telisotuzumab Vedotin (ABBV-399) Moves Through the Body as a Monotherapy in Adult Participants With Previously Treated Non-Squamous Non-Small Cell Lung Cancer (NSCLC)
Recruitment Recruiting
Gender both
Phase Phase II
Variant Requirements No
Sponsors AbbVie
Indications
Therapies
Age Groups: adult | senior
Covered Countries USA | ISR

Facility Status City State Zip Country Details
Cancer Specialists of North Florida - Jacksonville - AC Skinner Parkway /ID# 270899 RECRUITING Jacksonville Florida 32256 United States Details
Comprehensive Hematology Oncology /ID# 270422 RECRUITING Saint Petersburg Florida 33701-4732 United States Details
Astera Cancer Care /ID# 272359 RECRUITING East Brunswick New Jersey 08816-4096 United States Details
Clinical Research Alliance - Westbury /ID# 270455 RECRUITING Westbury New York 11590 United States Details
Guthrie Robert Packer Hospital /ID# 270316 RECRUITING Sayre Pennsylvania 18840 United States Details
Northwest Medical Specialties Tacoma /ID# 270534 RECRUITING Tacoma Washington 98405 United States Details
Meir Medical Center /ID# 270071 RECRUITING Kfar Saba HaMerkaz 4428164 Israel Details
Rambam Health Care Campus /ID# 270078 RECRUITING Haifa 3525408 Israel Details
Shaare Zedek Medical Center /ID# 270095 RECRUITING Jerusalem 9103102 Israel Details
Rabin Medical Center /ID# 270087 RECRUITING Petah Tikva 4941492 Israel Details
*Shaded cells indicate that there was no data available from clinicaltrials.gov for the field